These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12960609)

  • 1. Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor.
    Lisman T; Adelmeijer J; Nieuwenhuis HK; de Groot PG
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):557-62. PubMed ID: 12960609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
    Lisman T; Bijsterveld NR; Adelmeijer J; Meijers JC; Levi M; Nieuwenhuis HK; De Groot PG
    J Thromb Haemost; 2003 Nov; 1(11):2368-73. PubMed ID: 14629471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.
    Morishima Y; Kamisato C; Honda Y
    J Thromb Thrombolysis; 2020 Jan; 49(1):94-99. PubMed ID: 31396790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
    Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B; Ingerslev J
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C accelerates clot lysis by virtue of its anticoagulant activity.
    de Fouw NJ; van Tilburg NH; Haverkate F; Bertina RM
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):201-10. PubMed ID: 8388739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.
    Lisman T; Mosnier LO; Lambert T; Mauser-Bunschoten EP; Meijers JC; Nieuwenhuis HK; de Groot PG
    Blood; 2002 Jan; 99(1):175-9. PubMed ID: 11756168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.
    Carter RLR; Talbot K; Hur WS; Meixner SC; Van Der Gugten JG; Holmes DT; Côté HCF; Kastrup CJ; Smith TW; Lee AYY; Pryzdial ELG
    J Thromb Haemost; 2018 Nov; 16(11):2276-2288. PubMed ID: 30176116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
    Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
    Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
    Gerotziafas GT; Depasse F; Chakroun T; Samama MM; Elalamy I
    Thromb Haemost; 2004 Mar; 91(3):531-7. PubMed ID: 14983229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro.
    Hauptmann J; Kaiser B
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):577-82. PubMed ID: 8218854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
    Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of clot lysis time by a direct thrombin inhibitor melagatran mediated by paradoxical enhancement of thrombin generation: comparison with a direct factor Xa inhibitor edoxaban.
    Morishima Y; Kamisato C; Honda Y
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):209-215. PubMed ID: 33560005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran.
    Ammollo CT; Semeraro N; Carratù MR; Colucci M; Semeraro F
    J Pharmacol Exp Ther; 2016 Feb; 356(2):305-13. PubMed ID: 26578266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
    Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.